NCT06064630

The Effect of Telemedicine-Based APAP Management on 24-Hour Ambulatory Blood Pressure in Patients With Obstructive Sleep Apnea

Completed NA Last updated 21 January 2026

What this trial tests

NA trial testing Automatic continuous positive airway pressure in Sleep Apnea, Obstructive in 344 participants. Completed in 18 November 2024.

Timeline

1 November 2023

Primary endpoint
16 November 2024

18 November 2024

Quick facts

Lead sponsor	Peking University People's Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	344
Start date	1 November 2023
Primary completion	16 November 2024
Estimated completion	18 November 2024
Sites	1 location across China

Drugs / interventions tested

• Automatic continuous positive airway pressure

Conditions studied

• Sleep Apnea, Obstructive — all drugs for Sleep Apnea, Obstructive →

Sponsor

Peking University People's Hospital

Who can join

Adults 18 to 75, any sex, with Sleep Apnea, Obstructive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Epidemiological studies have shown that OSA is closely related to the occurrence and development of cardiovascular diseases, especially hypertension. At present, there are 66 million patients with moderate to severe OSA in China, and the current diagnosis and treatment of OSA is mainly completed in the sleep center of the hospital, which is time-consuming and laborious, resulting in the delayed diagnosis and treatment of a large number of patients, making about 80% of potential OSA patients have not been diagnosed and treated in time. With the development of the Internet technologies, telemedicine has been increasingly applied to the diagnosis, treatment and management of chronic diseases with its advantages of convenience, interactivity, efficiency, sharing, coherence and breaking through the limitations of time and space. Our center has initially built a remote diagnosis and treatment management model for OSA. Compared with the traditional medical model, the medical and health economic analysis shows that the OSA diagnosis and treatment model based on telemedicine is more cost-effective, but its clinical efficacy needs to be further verified. Hypertension is a common complication in OSA patients, and continuous positive airway pressure (PAP) has a significant hypertensive effect in the treatment of OSA. However, whether clinical management based on remote diagnosis and treatment mode can achieve the same therapeutic effect as traditional face-to-face diagnosis and treatment mode in improving ambulate blood pressure in OSA patients needs to be further clarified. This study will compare the improvement of 24 hour ambulatory blood pressure in patients under the Telemedicine-Based APAP Management and the traditional outpatient management through a single-center randomized controlled trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.